Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) ≠ Institute of Public Law
  • (-) = Landewe, R.

Refine Results

Resource Type

Availability

Creation Date

Show more

Author

Show more

Language

Search results

  • RSS Feed
(73 - 96 of 365)

Pages

Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA
ADDING ULTRASOUND TO THE TREAT-TO-TARGET STRATEGY SHOWS NO BENEFIT IN ACHIEVEMENT OF REMISSION: RESULTS FROM THE BIODAM COHORT
THE ROLE OF INDIVIDUAL AND COUNTRY-LEVEL SOCIO-ECONOMIC FACTORS IN WORK PARTICIPATION IN PATIENTS WITH SPONDYLOARTHRITIS ACROSS 22 COUNTRIES WORLDWIDE: RESULTS FROM THE COMOSPA STUDY
FAMILY MATTERS: VALUE OF FAMILY HISTORY OF SPONDYLOARTHRITIS IN THE DIAGNOSTIC WORK-UP OF PATIENTS WITH CHRONIC BACK PAIN: RESULTS FROM THE SPACE AND DESIR COHORTS
INDUCTION OF SUSTAINED REMISSION IN EARLY INFLAMMATORY ARTHRITIS WITH THE COMBINATION OF INFLIXIMAB PLUS METHOTREXATE, METHOTREXATE ALONE OR PLACEBO: THE DINORA TRIAL
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
EFFECT OF NSAID CONSUMPTION ON CARDIOVASCULAR EVENTS IN SPONDYLOARTHRITIS
DEFINING CLINICALLY IMPORTANT WORSENING BASED ON ASDAS-CRP FOR AXIAL SPONDYLOARTHRITIS: A DATA-BASED CONSENSUS BY THE ASSESSMENT IN SPONDYLOARTHRITIS INTERNATIONAL SOCIETY (ASAS)
Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of The EULAR recommendations for the management of rheumatoid arthritis
2016 update of the EULAR recommendations for the management of early arthritis
ARE MRI-DETECTED EROSIONS SPECIFIC FOR RA? A LARGE EXPLORATIVE CROSS-SECTIONAL STUDY
TUMOR NECROSIS FACTOR INHIBITOR TREATMENT REDUCES SPINAL RADIOGRAPHIC PROGRESSION IN ANKYLOSING SPONDYLITIS BY DECREASING DISEASE ACTIVITY: A LONGITUDINAL ANALYSIS IN A LARGE PROSPECTIVE COHORT
CHANGE IN MRI STRUCTURAL LESIONS IN THE SACROILIAC JOINT AFTER TWO YEARS OF ETANERCEPT THERAPY IN COMPARISON TO A CONTEMPORARY CONTROL COHORT
SYSTEMATIC REVIEW OF RHEUMATOID ARTHRITIS CLINICAL STUDIES: SUBOPTIMAL STATISTICAL ANALYSIS OF RADIOLOGICAL DATA
CHANGE IN SACROILIAC JOINT STRUCTURAL RADIOGRAPHIC DAMAGE AFTER TWO YEARS OF ETANERCEPT THERAPY IN COMPARISON TO A CONTEMPORARY CONTROL COHORT IN NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
INEQUITY IN BIOLOGIC DMARD PRESCRIPTION FOR SPA ACROSS THE GLOBE. RESULTS FROM THE ASAS COMOSPA STUDY
Presence of multiple spondyloarthritis (SpA) features is important but not sufficient for a diagnosis of axial spondyloarthritis: data from the SPondyloArthritis Caught Early (SPACE) cohort
THE ASSESSMENT OF THE DUTCH QUALITY REGISTRY RHEUMATOID ARTHRITIS QUALITY INDICATORS IN THREE PILOT HOSPITALS
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
CLINICAL WORSENING ACCORDING TO THE PATIENT IS INFREQUENT IN AXIAL SPONDYLOARTHRITIS: RESULTS OF THE ASAS-FLARE STUDY IN 1169 PATIENTS
FOUR-YEAR IMAGING OUTCOMES IN AXIAL SPONDYLOARTHRITIS PATIENTS TREATED WITH CERTOLIZUMAB PEGOL, INCLUDING PATIENTS WITH ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
DUAL TRAJECTORIES OF DISEASE ACTIVITY AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ANKYLOSING SPONDYLITIS
Performance of the ASAS classification criteria for axial and peripheral spondyloarthritis: a systematic literature review and meta-analysis
Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts

Pages